Earnings call: DHC reports strong FFO growth and strategic moves in Q4

  • Investing.com
  • Stock Market News
Earnings call: DHC reports strong FFO growth and strategic moves in Q4
Credit: © Reuters.

Diversified Healthcare Trust (NASDAQ: DHC ) has announced significant operational and financial improvements in its fourth-quarter and year-end results. The company reported a substantial increase in normalized funds from operations (FFO) and cash basis net operating income (NOI).

DHC also highlighted strategic financial maneuvers including the issuance of zero coupon senior secured notes and the acquisition of Aleris common shares. The company's Senior Housing Operating Portfolio (SHOP) segment experienced revenue and NOI growth, with expectations for continued occupancy and revenue per available room (RevPAR) growth in 2024.

DHC's management provided insights into their office portfolio, financing strategies, and future capital expenditure plans.

Key Takeaways

  • DHC's normalized FFO rose by 207% to $41.1 million.
  • Cash basis NOI increased by 43% to $236.2 million.
  • The company issued $940.5 million in zero coupon senior secured notes and regained debt covenant compliance.
  • DHC acquired 34% of Aleris common shares and sold eight non-core properties.
  • SHOP segment saw increased revenue and NOI due to occupancy gains and rate increases.
  • Occupancy growth of 300 to 400 basis points and RevPAR growth of 10% to 12% are expected in 2024.
  • A $450 million credit facility was secured, and $250 million of senior notes were redeemed.
  • The company ended the quarter with $246 million in cash and a portfolio valued at $7.2 billion.
  • Plans to invest $250-270 million in 2024, focusing on senior living communities.
  • SHOP NOI guidance for 2024 is $120-140 million, with 400 basis points of occupancy growth expected.

Company Outlook

  • DHC expects to continue growing occupancy and RevPAR in 2024.
  • The company's investment focus will remain on senior living communities.
  • CapEx for 2025 is projected to be between $230-250 million, including investments in medical office building (MOB) properties.

Bearish Highlights

  • The company did not specifically highlight any bearish aspects during the earnings call.

Bullish Highlights

  • DHC's strategic financial activities and operational improvements indicate a positive outlook.
  • The SHOP segment's performance and the company's acquisition of Aleris shares suggest a bullish stance on the healthcare real estate sector.


  • There were no specific misses reported during the earnings call.

Q&A Highlights

  • Executives discussed the potential for increasing share prices, with the possibility of reaching significant highs.
  • Demand for SHOP assets was noted as a positive influence on valuations.
  • The company outlined its CapEx plans for the SHOP portfolio, expecting a decrease after 2025.

Diversified Healthcare Trust's fourth-quarter results reflect a year of strategic financial management and operational success. The company's focus on repaying debt, securing new financing, and investing in high-potential segments like senior living communities positions DHC for continued growth.

With a solid portfolio and a clear plan for capital expenditures, DHC aims to strengthen its presence in the healthcare real estate market. Investors and stakeholders will be watching closely as the company navigates the upcoming year with optimism and strategic focus.

InvestingPro Insights

Diversified Healthcare Trust (DHC) has shown a robust performance in its latest financial results, with marked improvements in key financial metrics. To provide further context to these results, here are some insights based on real-time data from InvestingPro and InvestingPro Tips that could help investors understand the company's current valuation and performance trends.

InvestingPro Data indicates a market capitalization of approximately $771.74 million, which is reflective of the company's size and market presence. Despite operational successes, DHC is trading at a low Price / Book multiple of 0.32, suggesting that the company's assets may be undervalued in the market. This could present an opportunity for investors looking for potential value stocks.

The company's revenue has grown by 7.97% over the last twelve months as of Q3 2023, indicating a positive trajectory in DHC's financial performance. However, the company has a negative P/E Ratio of -2.61, which has further declined to -3.13 when adjusted for the last twelve months as of Q3 2023. This metric highlights that the company is currently not profitable, a fact that is also supported by an InvestingPro Tip which notes that analysts do not anticipate the company will be profitable this year.

On a positive note, DHC has maintained dividend payments for 26 consecutive years, with a current dividend yield of 1.25%. This consistency in returning value to shareholders could be an attractive aspect for income-focused investors.

InvestingPro Tips also suggest that DHC's stock price movements are quite volatile, which aligns with the high price volatility mentioned. This could be an important consideration for investors who are sensitive to market fluctuations.

For those interested in a deeper analysis, InvestingPro offers additional tips that can provide more nuanced insights into DHC's financial health and future prospects. There are 13 additional InvestingPro Tips available for DHC, which can be explored further at https://www.investing.com/pro/DHC.

Investors looking to capitalize on these insights and the full range of features offered by InvestingPro can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

Full transcript - Diversified Healthcare Trust (DHC) Q4 2023:

Operator: Good morning, and welcome to the Diversified Healthcare Trust Fourth Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the call over to Melissa McCarthy, Manager of Investor Relations. Please go ahead.

Melissa McCarthy: Thank you, and good morning. Welcome to the fourth quarter 2023 conference call for Diversified Healthcare Trust. Joining me on today's call are Chris Bilotto, President and Chief Executive Officer; and Matt Brown, Chief Financial Officer and Treasurer. Today's call includes a presentation by management, followed by a question-and-answer session with sell-side analysts. I would like to note that the recording and retransmission of today's conference call are strictly prohibited without the prior written consent of the Company. Today's conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward-looking statements are based upon DHC's beliefs and expectations as of today, Tuesday, February 27, 2024. The Company undertakes no obligation to revise or publicly release the results of any revision to the forward-looking statements made in today's conference call other than through filings with the Securities and Exchange Commission, or SEC. In addition, this call may contain non-GAAP numbers, including normalized funds from operations or normalized FFO, net operating income or NOI, and cash basis net operating income or cash basis NOI. Reconciliations of net income or loss to these non-GAAP figures are available in our financial results package, which can be found on our website at www.dhcreit.com. Actual results may differ materially from those projected in any forward-looking statements. Additional information concerning factors that could cause those differences is contained in our filings with the SEC. Investors are cautioned not to place undue reliance upon any forward-looking statements. And finally, we will be providing guidance on this call, including short cash basis net operating income, or SHOP cash basis NOI. We are not providing a reconciliation of these non-GAAP measures as part of our guidance because certain information required for such reconciliation is not available without unreasonable efforts or at all such as gains or losses or impairment charges related to the disposition of real estate. Now I would like to turn the call over to Chris.

Chris Bilotto: Thank you, Melissa. Good morning, everyone, and thank you for joining our call. Last evening, DHC reported fourth quarter and year-end results, along with our January SHOP performance updates that reflect operating and financial improvements across our portfolio. On today's call, I will begin by providing you with an update on the quarter's operational performance and recent events and then discuss DHC's strategic initiatives as we look towards 2024 and beyond. Later, Matt will discuss the financial results and balance sheet in greater detail and provide full-year guidance and targets for our SHOP segment. 2023 was a pivotal year for DHC as we made significant progress with operational performance across our sectors contributing to a full-year 2023 increase to normalized FFO by 207% to $41.1 million. Throughout the year, we refreshed or underwent full renovations at nearly 65 of our SHOP communities, serving as a stepping stone for occupancy and NOI growth and contributing to our 2023 cash basis NOI increase to $236.2 million or 43% over the prior year. In December, we took a meaningful step to support our growth with the issuance of $940.5 million zero coupon senior secured notes using the proceeds to repay in full all $700 million of the outstanding debt maturing in 2024 and simultaneously regaining debt covenant compliance. On February 16, we executed our purchase right and acquired approximately 34% of the currently outstanding Aleris common shares at the predetermined tender offer price for a total purchase price of $14.9 million. AlerisLife is our largest operator, managing 119 communities across our SHOP segment. During 2023, we sold eight non-core properties located in markets where we believe there is minimal NOI growth potential or with properties that require excess of capital investment. Currently, we are marketing for sale on additional 9 non-core properties, mostly within our office portfolio with estimated sales proceeds of $60 million to $70 million. However, we are in the early innings with respect to the demand outlook from buyers and overall execution of these sales. Turning to our SHOP performance. For the quarter, revenue increased from the prior year by more than $26 million and sequentially by $1.2 million, primarily driven by occupancy gains and corresponding rate increases. Notably, NOI increased $8.1 million from the prior year, resulting in an NOI margin increase of 250 basis points. NOI margin were down sequentially due to increased labor, food, utility and insurance expenses. Across our SHOP segment, we ended the fourth quarter with occupancy of 79.3%, an increase of 300 basis points and an average monthly rate increase of 5.5% year-over-year. Fundamental supported the senior living industry remains strong entering 2024 driven by continual growth within the 80-plus population, a decrease in new supply and moderating wage and labor costs. We maintain an active asset management role with our operators principally focused on deployment of strategic ROI capital, providing data and analytics to support revenue growth and cost efficiency opportunities along with routine portfolio-wide evaluation of market trends and optimization opportunities across segments and acuity levels. These focus areas, along with those initiated from our operators, have contributed to our organic growth and have also helped identify additional opportunities, including the following: First, AlerisLife transition to annual rental rate increases effective each January. And for 2024, included a rate increase at the majority of their communities, ranging from 5% to 10%, depending on communities in the markets where they reside. On average, this includes a 7% rate increase. And while early in the year, our January 2024 SHOP results point to improved NOI and margin expansion in part from these changes. Second, in December, we gave notice of termination to one of our operating partners following a comprehensive review of a portfolio of 13 non-performing communities with locations in Wisconsin and Illinois. At year-end 2023, these collective communities contributed negative EBITDA of $3.2 million, and occupancy of 69%. We expect to transition these communities during the first half of 2024 with operations to be assumed by another of our third-party operators, Charter Senior Living. Charter has demonstrated significant success turning around 17 DHC communities currently under their management. Since its onboarding in 2021, Charter has increased occupancy from 76% at the time of transition to 87%, an increased NOI from $1.3 million to $5.9 million in Q4 2023. We expect there will be minimal disruption during the transition period and anticipate this will lead to meaningful improved operating and financial performance towards the back half of the year and into future years. Capital deployment continues to be a priority across our communities to ensure we are offering a best-in-class experience for current and future residents. Further, the current slowdown with new construction deliverables and select markets creates an environment that is right for organic growth and stability. During 2023, we invested $183 million of maintenance and value-enhancing capital across our SHOP communities, which included cosmetic or full renovations at nearly 65 communities. These investments, coupled with operational improvements that the community serve as a platform to drive performance. We expect to continue with improvements across our communities into 2024 with roughly 25 refresh projects currently underway, specifically targeted in communities where we expect improvement to enable higher rents and occupancy. Across our SHOP segment, in 2024, we are forecasting to end the year with occupancy growth of 300 basis points to 400 basis points, RevPAR growth of 10% to 12%, along with NOI improvements, which Matt will speak to in more detail. Turning to our Office Portfolio. We ended the quarter with 102 medical office and life science assets containing 8.6 million square feet with same-store occupancy of 92.2% and a weighted average lease term of 5.7 years. Leasing activity during the fourth quarter included new and renewal leases of 200,000 square feet at weighted average rents that were 18.1% higher than prior rents for the same space. Notably, quarterly activity included a renewal in Lubbock, Texas, with a full building medical office user for 56,000 square feet for a 10-year term and a rent increase of 13%, along with the renewal of one of our multi-tenant properties in Albuquerque, New Mexico, with the medical office tenant occupying 59,000 square feet for three years with a rental rate increase of 29%. For the full-year 2023, we executed 886,000 square feet of leasing activity with an average rent roll up 11.1% and overall improvement over the prior year. When looking at DHC's upcoming lease expirations in 2024, we have 7.1% of our annualized revenue expiring, of which close to 4.5% are known vacates primarily driven by three properties occupied by single tenants and located in St. Louis, Missouri; Durham, North Carolina; and Phoenix, Arizona. We are actively marketing these properties for lease while also evaluating strategic alternatives, including potential repositioning and dispositions. Despite some of these known vacates, we are off to an active start this year, having signed 65,000 square feet of new and renewal leases, reflecting a 14% increase in rents. Our pipeline remains healthy with approximately 650,000 square feet of total leasing activity and includes close to 390,000 square feet of potential absorption. Looking ahead, we remain optimistic about the outlook for our SHOP segment in 2024 and beyond. We are encouraged by the performance trends and remain steadfast in our commitment to identifying and pursuing capital investment opportunities to support sustainable performance improvement. As we consider future capital needs, we maintain our outlook to identify and sell non-core assets and are currently in the process of evaluating financing options for select properties across our portfolio along with agency financing giving our unencumbered senior housing portfolio. I will now turn the call over to Matt to review our financial results. Matt?

Matthew Brown: Thanks, Chris, and good morning, everyone. Before covering the results for the quarter, I wanted to highlight the bond offering we completed in December. We issued $940 million of zero coupon secured notes due in January 2026 with a one-year extension option. Net proceeds from this transaction were approximately $730 million and were used to repay and terminate our $450 million secured credit facility and redeemed $250 million of senior notes that were scheduled to mature in May. The bonds are secured by 95 properties, including medical office, life science and triple net leased senior living communities and wellness centers. We have provided additional aggregate information on this portfolio of properties in our quarterly earnings presentation. As a result of the transaction, we have no debt maturing until June 2025 and have regained compliance with our debt covenants, which allows us to issue and/or refinance debt, something we have not been able to do since May 2021. As a result of these financing activities, we have concluded that we no longer have substantial doubt about our ability to continue as a going concern. Now turning to the results for the quarter. Normalized FFO for the fourth quarter was $8.1 million or $0.03 per share and included $2.7 million or $0.01 per share of non-cash amortization of the discount associated with the zero coupon secured bond. On a run rate basis, this non-cash amortization is expected to total $20.7 million or $0.09 per share for the first quarter and $86.8 million or $0.36 per share for the full-year of 2024. Our consolidated same-property cash basis NOI was $56.3 million, representing an $11.9 million or 26.8% year-over-year improvement. The changes by segment are as follows: Office same-property cash basis NOI was $29.5 million, representing a year-over-year improvement of $1 million or 3.5%, mainly driven by free rent burning off. On a sequential quarter basis, cash basis NOI improved $645,000 or 2.2%, mainly driven by reductions in utilities that were higher in Q3 due to seasonal cooling. SHOP same-property cash basis NOI was $16.3 million, representing another significant year-over-year increase of more than $10 million. On the revenue side, increases in occupancy and average monthly rate were the main drivers. These revenue increases were partially offset by expense increases, most notably wages and benefits of $8 million in insurance increases. While we saw an increase in wages and benefits, it is important to note that contract labor decreased $8.7 million over the prior year period. Turning to liquidity, financing strategies and CapEx. We ended the quarter with $246 million in cash. Our portfolio is comprised of 371 properties with a gross book value of $7.2 billion. With a significant amount of unencumbered assets, including all properties in our SHOP segment, our financing focus in 2024 is as follows: Issuing CMBS debt secured by certain of our unencumbered medical office and life science properties, with target proceeds to exceed $150 million, which will be used to enhance liquidity. Issuing agency debt with certain of our unencumbered SHOP properties with the use of proceeds being used to repay our $500 million of 9.75% on secured notes, which become prepayable without penalty in June of this year. Based on the makeup of our portfolio, we have more than enough stabilized communities to achieve this financing strategy. In the fourth quarter, we invested $79 million in our properties, including $19 million in our Office segment and $56 million in our SHOP segment. For the full year of 2023, we invested $253 million in our properties, in line with the CapEx guidance provided on our Q3 earnings call, including $60 million in our Office segment and $183 million in our SHOP segment. As we have stated, continued investment in our senior living communities is an important component to support the NOI recovery. As part of our 2024 business plan, we have rationalized certain CapEx spend to ensure we are generating appropriate returns on our investment. With that said, in 2024, we expect to spend between $250 million and $270 million, including approximately $190 million to $200 million in our senior living communities. Looking forward, we expect full-year 2024 SHOP NOI to range from $120 million to $140 million, with most of the growth over 2023 occurring during the second half of the year. This SHOP NOI guidance assumes occupancy increasing approximately 400 basis points, which represents the high end of our occupancy range to 83% by year-end 2024. That concludes our prepared remarks. Operator, please open the line for questions.

Operator: We will now begin the question-and-answer session. [Operator Instructions] The first question today comes from Bryan Maher with B. Riley. Please go ahead.

Bryan Maher: Thank you and good morning. Before I move on to my question, I just wanted to clarify, you said SHOP NOI for 2024 back-end loaded, but $120 million to $140 million, is that correct?

Matthew Brown: That is correct.

Bryan Maher: Perfect. Thank you. Sticking with SHOP though, on the margin side, I mean, one of the questions I get most from the buy side as it relates to the percentage margin, right, which has been kind of hanging out in that five to 10 range, obviously, better at the AlerisLife properties than the other operators, and it was pleasant surprise to hear that you're going to transition some of those assets. But what's been the biggest hang-up there? And I'm assuming with your $120 million to $140 million guidance that you're expecting some major alleviation on that front. But can you just walk us through what's been the hang up and how that dissipates?

Matthew Brown: Sure. Bryan, I can start that. So we definitely expect in 2024 margin expansion, a lot of that is going to come from the topline. As we talked about, we're expecting occupancy to grow 300 to 400 basis points in the year. We're going to continue bringing rents more in line with market as we enter new leases with residents. I think as an industry with inflation where it's been, the expense side has definitely been pressured and it is a huge focus of our operators to not just grow the topline to drive that NOI growth, but to also really manage and rationalize the operating expenses at our communities.

Chris Bilotto: And the other thing I would add on that, Bryan, is as you may be aware, we're kind of at that tipping point with occupancy kind of being closer to the 80% threshold. And I think as we continue to advance occupancy upwards of kind of – we talked about the 300 to 400 basis points, we expect more to flow down to the bottom line. So certainly, we would expect incremental improvement in addition to some of those things that Matt referenced specifically attributed to occupancy.

Bryan Maher: Okay. Sticking with SHOP for a minute, can you tell us what compelled the repurchase of the AlerisLife position that you previously held?

Chris Bilotto: Yes. I mean, look, I think that on the onset, there was a tender offer, which everyone is aware of with the opportunity to kind of rightsize Aleris to control costs. And I think at the end, being in a position with kind of a more streamlined company and being able to purchase those shares at that same tender offer price is compelling. And I think further Aleris manages about 119 of our communities. And so I think there's aligned interest in kind of that investment.

Bryan Maher: And then on the SHOP assets in general. I mean, I'm sure you're aware of Welltower (NYSE: WELL ) buying Affinity, I think it was announced maybe 10 days ago for just under $1 billion, which would equate to about $250,000 a key. I think clearly, your assets aren't trading anywhere near that. And the upside to your share price common should you move towards that direction from $50,000, $60,000 a key to $100,000 to $150,000 is huge. I mean, can you give us what your thoughts are related to the marketplace for SHOP assets, given the broader dynamic that you talked about, which is lower supply and more people moving into the age group of going into the communities. I mean it seems like the demand is there. What's your view on the impact on valuations of what you own?

Chris Bilotto: Yes. I mean I think a couple of things. I mean we're certainly familiar with the headlines with some of these larger trades. There's different dynamics that go into those metrics and, I guess, overall cap rates and valuations assigned to the different kind of product type. But I think, in general, I would view this as a good kind of comp for the industry. And I think kind of going back to your comment, when we look across our portfolio, we have a very large presence in kind of strong growing markets like Southern Florida, Atlanta, Houston, Charlotte, where a lot of our units reside. And I would say within those, these are kind of institutional quality properties where we invest in meaningful capital, and we think there's continued upside. And so when you combine kind of some of these stronger markets where we're located, which I think across our portfolio represents a substantial portion of our units combined with the opportunity to continue growing NOI as we alluded to in some of our prepared remarks, I think, overall, seeing kind of those comps on some of those headlines, I think, provides further justification about overall increased values across the sector. And so I think seeing that and seeing those comps, I think, bodes well for senior living as a whole.

Bryan Maher: Well, just real last for me. The SHOP numbers you gave for CapEx this year, $190 million to $200 million, if you're successful at getting that deployed, is that substantially it? Or do you expect more to flow into 2025?

Matthew Brown: Bryan, I think that in 2025, the numbers will probably be a little bit less than 2024 for the SHOP portfolio. We are thinking in aggregate CapEx in 2025 is probably somewhere in the $230 million to $250 million range. So it's still a little higher than normal. But after 2025, we expect it to come down very significantly. I will also say that in prior modeling that we've done, we were thinking that CapEx was going to be in excess of $300 million in each of 2024 and 2025. So we are really tightening and sharpening the pencil here with the level that we provided on today's call. And the result of that is obviously less financing needs in 2024 that we highlighted on the call.

Bryan Maher: You said $230 million to $250 million just now for 2025, but you said they were in aggregate. So is that going to include MOB also?

Matthew Brown: Yes, that's all in, correct.

Bryan Maher: Thank you. That's all for me. Appreciate it.

Operator: [Operator Instructions] This concludes our question-and-answer session. I would like to turn the conference back over to Chris Bilotto, President and Chief Executive Officer, for any closing remarks.

Chris Bilotto: Thank you for joining our call today, and we look forward to seeing many of you at some of the upcoming conferences. Thank you.

Operator: The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or